EC Number   |
Natural Substrates |
|---|
    1.14.14.102 | (S)-N-methylcoclaurine + [reduced NADPH-hemoprotein reductase] + O2 |
- |
| 1.14.14.102 | (S)-N-methylcoclaurine + [reduced NADPH-hemoprotein reductase] + O2 |
one of the key enzymes in biosynthesis of benzylisoquinoline alkaloids in the opium poppy, CYP80B1 catalyzes the second to last step in the formation of (S)-reticuline, the last common intermediate in sanguinarine and morphine biosynthesis, overview |
| 1.14.14.102 | (S)-N-methylcoclaurine + [reduced NADPH-hemoprotein reductase] + O2 |
the catalyzes step 5 in the unique, cell type-specific biosynthesis of benzylisoquinoline alkaloids in the opium poppy, biosynthetic pathway leading from L-DOPA to morphine, overview |
| 1.14.14.102 | (S)-N-methylcoclaurine + [reduced NADPH-hemoprotein reductase] + O2 |
the enzyme catalyzes a key regulation step in morphine biosynthesis |
| 1.14.14.102 | (S)-N-methylcoclaurine + [reduced NADPH-hemoprotein reductase] + O2 |
the enzyme is involved in the sanguinarine biosynthetic pathway, overview |
| 1.14.14.102 | more |
the enzyme is necessary for synthesis of the central tetrahydrobenzylisoquinoline alkaloid intermediate (S)-reticuline |
| 1.14.14.102 | more |
the enzyme is necessary for synthesis of the central tetrahydrobenzylisoquinoline alkaloid intermediate (S)-reticuline. Accumulates in response to elicitor treatment |
